Trump Plans 100% Tariff on Imported Brand Drugs
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Trump administration prepared an order imposing a 100% tariff on imports of patented medications and their active ingredients, based on a draft seen by STAT
- White House has not responded to requests for comment on the pending tariff order, which could be announced as soon as Thursday
- Bloomberg first reported details of the planned tariffs, confirming the potential Thursday announcement timeline for the Trump administration’s move
- Drug manufacturers may qualify for exemptions under the proposed tariff order, though specifics of the exemption pathways remain unclear from the draft
Why it matters: Imported brand-name drugs could see significantly higher costs if the 100% tariff takes effect, directly impacting pharmaceutical companies that rely on global supply chains. The exemption process will likely determine both the policy’s enforceability and its real-world effect on drug prices.
